Walid Kamoun, Vice President and Global Head of Reasearch and Development Oncology at Servier, shared on LinkedIn:
“As I am scouting for new scientific data on brain tumor, I stumbled on this interesting review in Science Translational Medicine.
The Review summarizes the current standard of care and then examines the emerging strategies aimed at these constraints: locoregional delivery technologies, immunotherapy, biomarker-defined precision approaches, and adaptive clinical trial designs.
The authors highlight the translational and clinical studies shaping the field and discuss principles for developing more integrated therapeutic paradigms.
Thanks to Villa et al. for this a detailed review. It is always good to review where we stand.”
Authors: Genaro R Villa, Ashish D Patel, David A Reardon, E Antonio Chiocca
Read the full article.

You can also read ‘Brain Cancer: Causes, Symptoms, Diagnosis, and 2025 Advances in Treatment‘

Don’t miss the latest news in oncology: stay up to date with daily picks from OncoDaily.
OncoDaily™ | © 2023 – 2025
All rights reserved. Unauthorized reproduction, distribution, or transmission of any content on OncoDaily.com is strictly prohibited. For permission requests or inquiries, please contact OncoDaily directly. By accessing and using OncoDaily.com, you acknowledge and agree to comply with this copyright notice, as well as our Privacy Policy, Editorial Policy, Cookie Policy, and Disclaimer. Continued use of this website constitutes acceptance of all such terms and policies.
Phone number: +1 978 717 48 84
Email: info@oncodaily.com